SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A8D5D3842ECCA51C913CD5141DA26B3DF1424D414EC12A9722C497DF0BB8936CFF8001F4FAF3CCE93625AB72B6D1C0B3>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A8D5D3842ECCA51C913CD5141DA26B3DF1424D414EC12A9722C497DF0BB8936CFF8001F4FAF3CCE93625AB72B6D1C0B3
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A8D5D3842ECCA51C913CD5141DA26B3DF1424D414EC12A9722C497DF0BB8936CFF8001F4FAF3CCE93625AB72B6D1C0B3
http://www.w3.org/2000/01/rdf-schema#comment
"These results demonstrate that the activities of AR and mTOR pathways are maintained by KLK4 which may thus be a viable target for therapy"
xsd:string
http://purl.uniprot.org/uniprot/#_1C706C9318A8E998E25385EAD4734BBBF8057C5ECF43C9B225A0C91A9AB339147973306E47FC0C7AFF11FBE07C94A17F
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A8D5D3842ECCA51C913CD5141DA26B3DF1424D414EC12A9722C497DF0BB8936CFF8001F4FAF3CCE93625AB72B6D1C0B3
http://purl.uniprot.org/uniprot/Q96PT1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A8D5D3842ECCA51C913CD5141DA26B3DF1424D414EC12A9722C497DF0BB8936CFF8001F4FAF3CCE93625AB72B6D1C0B3
http://purl.uniprot.org/uniprot/#_Q96PT1-mappedCitation-23798432
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A8D5D3842ECCA51C913CD5141DA26B3DF1424D414EC12A9722C497DF0BB8936CFF8001F4FAF3CCE93625AB72B6D1C0B3